Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,651 | 124 | 98.5% |
| Education | $100.90 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $1,568 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,284 | 17 | $0 (2024) |
| Allergan, Inc. | $921.60 | 19 | $0 (2020) |
| CSL Behring | $452.15 | 12 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, LLC | $347.21 | 7 | $0 (2020) |
| Shionogi Inc | $326.47 | 3 | $0 (2024) |
| Ambu Inc. | $308.43 | 3 | $0 (2022) |
| ABBVIE INC. | $304.32 | 10 | $0 (2024) |
| Chiesi USA, Inc. | $166.16 | 4 | $0 (2024) |
| ZOLL Medical Corporation | $135.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $890.01 | 23 | La Jolla Pharmaceutical Company ($314.03) |
| 2023 | $1,111 | 25 | La Jolla Pharmaceutical Company ($349.98) |
| 2022 | $1,071 | 15 | La Jolla Pharmaceutical Company ($548.21) |
| 2021 | $1,296 | 19 | AstraZeneca Pharmaceuticals LP ($517.40) |
| 2020 | $468.30 | 9 | AstraZeneca Pharmaceuticals LP ($245.72) |
| 2019 | $1,192 | 21 | Allergan Inc. ($616.68) |
| 2018 | $319.00 | 7 | Allergan Inc. ($160.96) |
| 2017 | $403.60 | 9 | ZOLL Medical Corporation ($135.74) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 10/29/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 10/04/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 08/23/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Immunology | ||||||
| 08/20/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Gastroenterology | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: Rare Disease | ||||||
| 06/20/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $133.17 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $98.79 | General |
| 05/30/2024 | Mindray DS USA, Inc. | TE7 MAX (Device), TE X | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ULTRASOUND | ||||||
| 05/24/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 05/17/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 05/03/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Rare Disease | ||||||
| 03/22/2024 | La Jolla Pharmaceutical Company | — | Food and Beverage | In-kind items and services | $119.22 | General |
| 02/20/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Nasal High Flow | ||||||
| 02/09/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 01/24/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/13/2024 | Avanos Medical | ON-Q* PUMP AND ACCESSORIES (Device) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: SURGICAL PAIN | ||||||
| 01/11/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $123.65 | General |
| Category: Infections and Infectious Diseases | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $8.33 | General |
| 12/18/2023 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/07/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $52.06 | General |
| Category: EMERGENT HYPOTENSION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 266 | 546 | $1.4M | $84,937 |
| 2022 | 4 | 202 | 426 | $1.2M | $67,364 |
| 2021 | 5 | 198 | 456 | $419,300 | $74,871 |
| 2020 | 7 | 295 | 585 | $417,098 | $93,371 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 154 | 408 | $1.3M | $72,300 | 5.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 85 | $58,169 | $8,435 | 14.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 20 | 25 | $18,537 | $2,275 | 12.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 17 | $7,369 | $1,183 | 16.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 11 | $4,931 | $744.04 | 15.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 122 | 320 | $1.2M | $58,818 | 5.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 72 | $38,226 | $5,797 | 15.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 15 | 20 | $13,833 | $1,875 | 13.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 14 | $5,774 | $873.74 | 15.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 115 | 345 | $370,028 | $66,129 | 17.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 47 | $13,113 | $2,968 | 22.6% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 22 | 28 | $13,802 | $2,707 | 19.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 24 | $15,901 | $2,178 | 13.7% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 12 | 12 | $6,456 | $888.94 | 13.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 141 | 411 | $347,706 | $79,262 | 22.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 38 | 44 | $17,556 | $3,934 | 22.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 36 | 40 | $11,160 | $2,540 | 22.8% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 30 | 33 | $17,754 | $2,478 | 14.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 19 | 24 | $10,176 | $2,320 | 22.8% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 16 | 18 | $9,720 | $2,253 | 23.2% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2020 | 15 | 15 | $3,026 | $582.93 | 19.3% |
About Dr. Michael Rodricks, MD
Dr. Michael Rodricks, MD is a Anesthesiology healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497732879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Rodricks, MD has received a total of $6,751 in payments from pharmaceutical and medical device companies, with $890.01 received in 2024. These payments were reported across 128 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,651).
As a Medicare-enrolled provider, Rodricks has provided services to 961 Medicare beneficiaries, totaling 2,013 services with total Medicare billing of $320,543. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Anesthesiology, Critical Care Medicine
- Location Somerset, NJ
- Active Since 12/28/2005
- Last Updated 04/10/2024
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1497732879
Products in Payments
- GIAPREZA (Drug) $1,357
- AVYCAZ (Drug) $958.77
- LOKELMA (Drug) $763.12
- ANDEXXA (Biological) $635.10
- Kcentra (Biological) $411.35
- Fetroja (Drug) $326.47
- TEFLARO (Drug) $267.15
- CLEVIPREX (Drug) $166.16
- Impella (Device) $129.46
- PRALUENT (Drug) $114.23
- RELISTOR (Drug) $102.87
- TE7 MAX (Device) $96.03
- Veklury (Drug) $83.70
- VYNDAQEL (Drug) $81.33
- LifeVest (Device) $46.92
- AMPLATZER Vascular Plugs (Device) $41.40
- Haegarda (Biological) $40.80
- XIFAXAN (Drug) $29.04
- EXPAREL (Drug) $24.41
- BRIDION (Drug) $18.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Somerset
Dr. William Lee, M.d, M.D
Anesthesiology — Payments: $37,879
Dr. Attila Kett, M.d, M.D
Anesthesiology — Payments: $10,035
Dr. Jacob Shipley, M.d, M.D
Anesthesiology — Payments: $6,378
Dr. Sachin Shah, Md, MD
Anesthesiology — Payments: $4,383
Dr. Jeremy Baron, Md, MD
Anesthesiology — Payments: $1,072
Dr. Jill Bruton, D.o, D.O
Anesthesiology — Payments: $790.20